Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness.
Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness. J Mol Cell Biol. 2012 Aug; 4(4):207-20.
View in:
PubMed
subject areas
Animals
Benzamides
Cell Adhesion
Cell Line, Tumor
Cell Movement
Cell Proliferation
Epithelial-Mesenchymal Transition
Humans
Integrin alphaVbeta3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Mesoderm
Mice
Phenotype
Piperazines
Pyrimidines